DPN Pathology at blood–nerve barrier
Comparison version between v2 by Bruce Ren and v1 by Yukio Takeshita

In diabetic peripheral neuropathy (DPN), metabolic disorder by hyperglycemia progresses in pe-ripheral nerves. In addition to the direct damage to peripheral neural axons, the homeostatic mechanism of peripheral nerves is disrupted by dysfunction of the blood–nerve barrier (BNB) and Schwann cells. The disruption of the BNB, which is a crucial factor in DPN development and ex-acerbation, causes axonal degeneration via various pathways. Although many reports revealed that hyperglycemia and other important factors, such as dyslipidemia-induced dysfunction of Schwann cells, contributed to DPN, the molecular mechanisms underlying BNB disruption have not been sufficiently elucidated, mainly because of the lack of in vitro studies owing to difficulties in establishing human cell lines from vascular endothelial cells and pericytes that form the BNB.

1. Introduction

Diabetes mellitus, especially type 2 diabetes mellitus, affects approximately 463 million people worldwide and is expected to affect more than 700 million people by 2045 [1]. Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes mellitus and occurs in 30%–50% of patients with type 2 diabetes mellitus [2]. DPN is considered to occur in 100% of patients with type 1 diabetes mellitus within a disease duration of 15 years and in 30% of patients with type 2 diabetes mellitus within a disease duration of 25 years [3]. As overcoming DPN is an important global challenge, studies have been conducted on the pathology of DPN and have proposed various pathological hypotheses.

In peripheral nerve tissues, where glucose is taken up by non-insulin-dependent glucose transporters, most of the glucose is transported from blood vessels to peripheral nerve tissues, according to the concentration gradient. Hyperglycemia directly contributes to the elevation of intracellular glucose concentrations. In a hyperglycemic state, the polyol metabolic pathway is enhanced via increased activity of aldose reductase in peripheral nerve tissues [4]. Edema, degeneration, and ischemia of nerves are considered to occur via various mechanisms, such as osmotic stress, abnormal protein kinase C activity, increased oxidative stress, accumulation of advanced glycation end products (AGEs) due to impaired glucose metabolism, and decreased production of nitric oxide [5]. Notably, disruption of the blood–nerve barrier (BNB), a strict barrier system that stabilizes the internal environment of peripheral nerves, has been increasingly reported to be deeply involved in the onset and exacerbation of DPN with in vitro BNB models.

2. Anatomy of the BNB and Peripheral Nerves

Peripheral nerve tissues mainly compose the BNB, Schwann cells, and nerve axons. The BNB is mainly localized in the microvessels of peripheral nerves within the peripheral neural parenchyma (endoneurium) and consists of vascular endothelial cells bound by tight junction proteins, pericytes attached to the outer side of the vascular endothelial cells, and basal laminae covering these two types of cells. Like the blood–brain barrier (BBB) in the central nervous system, the BNB acts as a wall preventing the influx of harmful substances circulating in the blood into peripheral nerves [6]. The BBB is mainly composed of brain microvascular endothelial cells, pericytes, astrocytes, and the two distinct basement membranes. The BNB has a similar structure to the BBB, with the exception of lacking astrocytes (Figure 1A). It had previously been thought that the BNB was leaky compared to the BBB, as a result of the lack of astrocytes, but several reports showed that the BNB has a barrier function as robust as that of the BBB [7][8] and acts as an interface to maintain the microenvironment in peripheral nerves by expressing transporters for the transportation of nutrients, such as glucose and amino acids, as well as for the excretion of waste products [6][9]. The basement membrane in the BBB and BNB consists of a mixture of extracellular matrix proteins including collagen IV and laminin [10]. Laminin is a trimeric molecule comprising α-, β-, and γ-subunits and shows specific expression in the central and peripheral nervous systems [10]. We showed that laminin α4 was hardly expressed in the BNB compared with the BBB (Figure 1B), whereas α5, β1, β2, and γ1 were widely expressed in the BBB and BNB [11]. In experimental autoimmune encephalomyelitis, a relevant preclinical model of multiple sclerosis laminin α4 facilitates the transmigration of T lymphocytes across the BBB because integrin α6β1, a major counterpart receptor of laminin α4, is strongly expressed on all T lymphocytes [12]. These results showed that T lymphocytes, with integrin α6β1, migrated across the BNB through other factors (except for laminin α4 in peripheral autoimmune neuropathies), suggesting the BNB has its own barrier system because of a lack of laminin α4 in the BNB. On the other hand, laminin α5 plays a key role in the maintenance and repair of BBB after hypoxic injury and inflammation [13]. Therefore, we hypothesized that BNB-specific laminin expression without laminin α4 might promote almost the same properties as a barrier system as those with the BBB.

In contrast, Schwann cells surround the axons of neurons to form a myelin sheath, a structure responsible for saltatory conduction. Together with pericytes, Schwann cells are involved in providing nutrients to neurons and play a role in maintaining the microenvironment [14].





Figure 1. Comparative anatomy of the blood–brain barrier and blood–nerve barrier. (A) Peripheral nerve tissue consists of the blood–nerve barrier and axons of neurons wrapped in Schwann cells. Unlike the blood–brain barrier, which consists of vascular endothelial cells, pericytes, astrocytes, and basal laminae, the blood–nerve barrier consists of vascular endothelial cells, pericytes, and basal laminae. (B) Immunostaining with anti-laminin (α5 and 4) in the blood–brain barrier (BBB; brain; left panel) and blood–nerve barrier (BNB; median nerve; middle panel) from a postmortem 67-year-old man with amyotrophic lateral sclerosis and from a 67-year-old man with diabetic peripheral neuropathy (DPN; sural nerves; right panel). Laminin α5 immunoreactivity was localized to the microvessels. Only laminin α4 immunoreactivity was lost in the BNB. Bar 10 μm.

2.1. Establishment of BNB-Forming Cell Lines and Functions of Pericytes

2.1.1. Establishment of BNB-Forming Cell Lines

To clarify the mechanism underlying BNB disruption in DPN, we established temperature-sensitive immortalized cell lines of vascular endothelial cells and pericytes originating from human BNB (Figure 2A,B). We extracted endoneurial vessels from human sciatic nerves obtained at autopsy. Endothelial cells and pericytes were then isolated and cultured. These cells were immortalized by introducing the temperature-sensitive SV40 large T-antigen gene using the same retrovirus vector. The vascular endothelial cells were characterized by their spindle-fiber-shaped morphology, expression of von Willebrand factor, expression of tight junction-related molecules, and high electrical resistance, which were consistent with the characteristics of BNB-forming endothelial cells [7][15]. Pericytes were characterized by their cobblestone-shaped morphology and identified by their ruffled borders and the expressions of α-smooth muscle actin (α-SMA), PDGF-β receptor (PDGFβR), osteopontin, and desmin [16][17]. After our report, Vosef et al. established BNB-forming vascular endothelial cell lines derived from human sciatic nerves [18][19]. These cell lines were immortalized by introducing the SV40 large T-antigen gene. However, the continuous passage of immortalized cell lines by serial introduction of the SV40 large T-antigen gene may alter the morphology of cells, leading to a loss of their biochemical function [20]. The human cell lines derived from endothelial cells forming the BNB (hEC-BNB) and the pericytes forming the BNB (hPCT-BNB), established in the present study, were conditionally immortalized by introducing the temperature-sensitive SV40 large T-antigen gene (Figure 2C). The SV40 large T-antigen gene was inactivated by culturing at 37 °C, leading to a loss of immortalization. The cell lines were, therefore, considered to have physiological and biochemical functions similar to in vivo conditions [7][17].

Figure 2. Establishing the BNB cell lines that maintain BNB properties. (A) Morphology of hEC-BNB (human endothelial cells in BNB) is spindle-shaped. (B) Morphology of hPCT-BNB (human pericytes in BNB) is cobblestone-shaped. (C) Temperature-sensitive SV40 large T antigen. At 33 °C, TS-SV40-LT binds and inhibits p53 and Rb, which are strong tumor suppressors, leading to continuous cell proliferation. At 37 °C, TS-SV40-LT is inactivated, and the cells exhibit growth arrest and differentiate into endothelial cells. Scale bar represents 10 µm.

2.1.2. Function of Pericytes in the BNB

In the BBB, endothelial cells function as an important barrier; however, they alone cannot maintain the physiological barrier, and continuous “crosstalk” between cellular and non-cellular components surrounding these cells is considered essential for maintaining the barrier. Astrocytes have been recognized as important BBB regulators [21], and in recent years, pericytes have also been described as important BBB regulators [22][23]. In 2010, Armulik et al. reported transcytosis in BBB-forming endothelial cells, leading to increased permeability of the BBB in pericyte-deficient mice. Since cells such as astrocytes are not present in the BNB, it is assumed that pericytes play an important role in regulating the BNB. Using BNB-forming cell lines, we previously demonstrated the following results: (1) pericyte culture supernatant increased the electrical resistance (trans-endothelial electrical resistance) and decreased the permeability of 14C-labeled inulin in endothelial cell lines originating from the BNB; (2) pericyte culture supernatant increased the expression of tight junction-related proteins (claudin-5, occludin) in endothelial cell lines originating from the BNB; (3) pericytes secrete physiologically active substances (angiopoietin-1 (Ang-1), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and a neurotropic factor (glial cell line-derived neurotrophic factor, GDNF)); (4) Ang-1 and VEGF secreted by pericytes decreased the expression of claudin-5, leading to a tendency to decrease BNB function; and (5) bFGF and GDNF, in contrast, increased the expression of claudin-5 [24]. These findings demonstrate that pericytes play an important role as BNB regulators.

2.1.3. Construction of a New In Vitro BNB Model

BNB plays crucial roles in the maintenance of peripheral nervous system homeostasis and in the pathogenesis of DPN. The BNB components (pericytes and basement membrane such as laminin α5, β1, γ1) have directly contact with the endothelial cells and participate the regulation of each barrier function. However, the mechanism of this regulation still remains unknown because of the non-existence of the in vitro human BNB model in which these components can directly come in contact with endothelial cells (Figure 3A,B). Recently, we constructed a new in vitro human BNB model that incorporated a multi-culturing system of these BNB components using the UpCell technology of Nunc (Figure 3C). In this model, firstly, hPCT-BNBs were cultured on the luminal side of the insert-membrane (Figure 3D). Secondly, hEC-BNBs were cultured in an UpCell dish with a coated temperature-responsive polymer, which can achieve sheet-like detachment of confluent cells and extracellular matrix by temperature-shifting to 20 °C. Then, sheet-like detachment of confluent hEC-BNBs were transferred onto the hPCT-BNBs. Confocal 3D analysis with live staining of each cell line showed that the multi-cultured insert constituted the two-layer structures, which consisted of hEC-BNBs and hPCT-BNBs. The layer of hPCT-BNBs was in direct contact with the hEC-BNBs (Figure 3E).

Figure 3. Construction of a new in vitro BNB model. (A) An ideal in vitro human BNB model. The endothelial cells form the monolayer. The BNB components (pericytes and basement membrane) are in direct contact with the monolayer of endothelial cells on the tissue culture insert. (B) An actual in vitro human BNB model. If endothelial cells are forcibly multi-cultured on the layer of pericytes, they disorderly laminate and cannot form the BNB due to the difference in growth speed of each cell line. (C) The Nunc UpCellTM technology. Temperature-responsive polymer is immobilized on the surface of the UpCellTM dish. The polymer-grafted surface shows reversible hydrophobic and hydrophilic properties across the threshold temperature of 20 °C. The cell-sheet is detached from the dish without harmful enzymes (e.g., trypsin or dispase) and attached to the hygroscopic sheet to transfer. (D) Multi-culturing systems. hPCT-BNBs were cultured on the luminal side of the cell culture insert membrane with 3µm pores. After flipping the cultured insert, hPCT-BNBs were cultured on the luminal side. hEC-BNBs were cultured in an UpCell dish. After incubation at 20 °C, the sheet of confluent hECs was detached and transferred onto the hPCT-BNBs. (E) Confocal 3D analysis with live staining of hEC-BNBs and hPCT-BNBs. Multi-cultured insert constituted the two-layer structures, which consisted of hEC-BNBs and hPCT-BNBs. The layer of hPCT-BNBs was close to the hEC-BNBs. Bar = 5 µm.


  1. Saeedi, P.; Petersohn, I.; Salpea, P.; Malanda, B.; Karuranga, S.; Unwin, N.; Colagiuri, S.; Guariguata, L.; Motala, A.A.; Ogurtsova, K.; et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projec-tions for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas 9 th edition. Diabetes Res. Clin. Pract. 2019, 157, 107843.
  2. Peltier, A.; Goutman, A.S.; Callaghan, B.C. Painful diabetic neuropathy. BMJ 2014, 348, 1799.
  3. Harati, Y. Diabetic neuropathies: unanswered questions. Neurol. Clin. 2007, 25, 303–317.
  4. Chung, S.; Ho, E.; Lam, K.; Chung, K.S. Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 2003, 14, 233–236
  5. Giri, B.; Dey, S.; Das, T.; Sarkar, M.; Banerjee, J.; Dash, S.K. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction infection cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomed. Pharmacother. 2018, 107, 306–328.
  6. Kanda, T. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J. Neurol. Neurosurg. Psy-chiatry 2013, 84, 208–212.
  7. Abe, M.; Sano, Y.; Maeda, T.; Shimizu, F.; Kashiwamura, Y.; Haruki, H.; Saito, K.; Tasaki, A.; Kawai, M.; Terasaki, T.; et al. Establishment and characterization of humanperipheral nerve microvascular endothelialcell lines:a new in vitro blood-nerve barrier (BNB) model. Cell. Struct. Funct. 2012, 37, 89–100.
  8. Poduslo, J.F.; Curran, G.L.; Berg, C.T. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc. Natl. Acad. Sci. USA 1994, 91, 5705–5709.
  9. Ubogu, E.E. The molecular and biophysical characterization of the human blood-nerve barrier: Current concepts. J. Vasc. Res. 2013, 50, 289–303.
  10. Cardoso, F.L.; Brites, D.; Brito, M.A. Looking at the blood‐brain barrier: molecular anatomy and possible investigation ap-proaches. Brain Res. Rev. 2010, 64, 328–363.
  11. Takeshita, Y.; Omoto, M.; Fujikawa, S.; Kanda, T. Immunohistochemical analysis of laminin components in the blood–nerve barrier and blood–brain barrier. Clin. Exp. Neuroimmunol. 2017, 8, 49–53.
  12. Wu, C.; Ivans, F.; Anderson, P.; Hallmann, R.; Vestweber, D.; Nilsson, P.; Robenek, H.; Tryggvason, K.; Song, J.; Korpos, E.; et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 2009, 15, 519–527.
  13. Kangwantas, K.; Pinteaux, E.; Penny, J. The extracellular matrix protein laminin‐10 promotes blood‐brain barrier repair after hypoxia and inflammation in vitro. J. Neuroinflamm. 2016, 13, 25.
  14. Stierli, S.; Imperatore, V.; Lloyd, A.C. Schwann cell plasticity‐roles in tissue homeostasis regeneration and disease. Glia 2019, 67, 2203–2215.
  15. Sano, Y.; Shimizu, F.; Nakayama, H.; Abe, M.; Maeda, T.; Ohtsuki, S.; Terasaki, T.; Obinata, M.; Ueda, M.; Takahashi, R.; et al. Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells. Cell Struct. Funct. 2007, 32, 139–147.
  16. Shimizu, F.; Sano, Y.; Maeda, T.; Abe, M.; Nakayama, H.; Takahashi, R.; Ueda, M.; Ohtsuki, S.; Terasaki, T.; Obinata, M.; et al. Peripheral nerve pericytes originating fromthe blood-nerve barrier expresses tightjunctional molecules and transporters asbarrier-forming cells. J. Cell Physiol. 2008, 217, 388–399.
  17. Shimizu, F.; Sano, Y.; Abe, M.; Maeda, T.; Ohtsui, S.; Terasaki, T.; Kanda, T. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J. Cell Physiol. 2011, 226, 255–266.
  18. Yosef, N.; Xia, R.H.; Ubogu, E.E. Developmentand characterization of a novel human invitro blood-nerve barrier model us-ingprimary endoneurial endothelial cells. J. Neuropathol. Exp. Neurol. 2010, 69, 82–97.
  19. Yosef, N.; Ubogu, E.E. An immortalized humanblood-nerve barrier endothelial cell line for invitro permeability studies. Cell Mol. Neurobiol. 2013, 33, 175–186.
  20. Takeshita, Y.R.; Ansohoff, R.M. Inflammatorycell trafficking across the blood-brainbarrier: Chemokine regulation and in vitromodels. Immunol. Rev. 2012, 248, 228–239.
  21. Abbott, N.J.; Rönnbäck, L.; Hansson, E. Astrocyte-endothelial interactions at theblood-brain barrier. Nat. Rev. Neurosci. 2006, 7, 41–53
  22. Lindahl, P.; Johansson, B.R.; Levéen, P.; Betsholtz, C. Pericyte loss and microaneurysmformation in PDGF-B-deficient mice. Science 1997, 277, 242–245
  23. Armulik, A.; Genové, G.; Mäe, M.; Nisancioglu, M.H.; Wallgard, E.; Niaudet, C.; He, L.; Norlin, J.; Lindblom, P.; Strittmatter, K.; et al. Pericytes regulate the bloodbrain barrier. Nature 2010, 468, 557–561.
  24. Shimizu, F.; Sano, Y.; Saito, K.; Abe, M.; Maeda, T.; Haruki, H.; Kanda, T. Pericyte-derived glial cellline-derived neurotrophic factor increase theexpression of claudin-5 in the blood-brainbarrier and the blood-nerve barrier. Neurochem. Res. 2012, 37, 401–409.